Improve drug development and patient outcomes
WATCH VIDEO
Cellworks CMO Dr. Michael Castro offers a fresh perspective on how Personalized Therapy Biosimulation is not a luxury, but a necessity to ‘stop treating in the dark’ and essential to achieving the Cancer Moonshot.
Precision by Biosimulation
FEATURED ARTICLE
Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot
FEATURED PUBLICATION
Differentiation Scoring Derived from Cellworks CBM Predicts Survival in MDS patients
FEATURED VIDEO
View how personalized therapy biosimulation works
FEATURED BLOG
Identifying the Right Target: The Importance of Driver Mutations in Personalized Medicine
Leader in Personalized Therapy Biosimulation Applies its Platform to Precision Drug Development…
Personalized Therapy Biosimulation Uncovers a Spectrum of Genomic Aberrations that Predict Respon…
STAY INFORMED
Top